Hologic Inc.

72.99+0.9200+1.28%Vol 655.10K1Y Perf -6.17%
Aug 12th, 2022 16:00 DELAYED
BID72.93 ASK73.05
Open72.27 Previous Close72.07
Pre-Market- After-Market72.91
 - -  -0.08 -0.11%
Target Price
79.60 
Analyst Rating
Moderate Buy 2.25
Potential %
9.06 
Finscreener Ranking
★★★+     52.50
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★★★     56.13
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★★★     67.47
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
44.33 
Earnings Rating
Neutral
Market Cap18.22B 
Earnings Date
27th Jul 2022
Alpha0.00 Standard Deviation0.10
Beta1.09 

Today's Price Range

72.0373.02

52W Range

66.5881.04

5 Year PE Ratio Range

-91.4040.30

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
2.23%
1 Month
3.75%
3 Months
-4.31%
6 Months
1.39%
1 Year
-6.17%
3 Years
45.02%
5 Years
91.07%
10 Years
267.15%

TickerPriceChg.Chg.%
HOLX72.990.92001.28
AAPL172.123.63002.15
GOOG122.652.83002.36
MSFT291.914.89001.70
XOM94.000.81000.87
WFC45.940.69001.52
JNJ165.30-1.8400-1.10
FB196.640.99000.51
GE79.931.03001.31
JPM122.131.99001.66
 
ProfitabilityValueIndustryS&P 500US Markets
63.40
37.30
45.70
18.60
29.00
RevenueValueIndustryS&P 500US Markets
5.23B
20.93
18.32
12.95
Earnings HistoryEstimateReportedSurprise %
Q03 20220.690.9537.68
Q02 20221.552.0733.55
Q01 20221.202.1780.83
Q04 20210.981.6164.29
Q03 20211.111.3319.82
Q02 20212.622.59-1.14
Q01 20212.142.8633.64
Q04 20201.222.0769.67
Earnings Per EndEstimateRevision %Trend
6/2022 QR0.69-4.17Negative
9/2022 QR0.63-13.70Negative
9/2022 FY5.548.63Positive
9/2023 FY3.63-3.46Negative
Next Report Date-
Estimated EPS Next Report0.69
Estimates Count6
EPS Growth Next 5 Years %14.40
Volume Overview
Volume655.10K
Shares Outstanding249.65K
Shares Float180.83M
Trades Count13.49K
Dollar Volume47.67M
Avg. Volume1.46M
Avg. Weekly Volume1.13M
Avg. Monthly Volume1.52M
Avg. Quarterly Volume1.73M

Hologic Inc. (NASDAQ: HOLX) stock closed at 72.99 per share at the end of the most recent trading day (a 1.28% change compared to the prior day closing price) with a volume of 655.10K shares and market capitalization of 18.22B. Is a component of S&P 500, Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 5814 people. Hologic Inc. CEO is Stephen P. Macmillan.

The one-year performance of Hologic Inc. stock is -6.17%, while year-to-date (YTD) performance is -4.66%. HOLX stock has a five-year performance of 91.07%. Its 52-week range is between 66.58 and 81.04, which gives HOLX stock a 52-week price range ratio of 44.33%

Hologic Inc. currently has a PE ratio of 12.20, a price-to-book (PB) ratio of 3.60, a price-to-sale (PS) ratio of 3.44, a price to cashflow ratio of 7.60, a PEG ratio of 2.32, a ROA of 17.84%, a ROC of 21.34% and a ROE of 35.90%. The company’s profit margin is 29.00%, its EBITDA margin is 45.70%, and its revenue ttm is $5.23 Billion , which makes it $20.93 revenue per share.

Of the last four earnings reports from Hologic Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.69 for the next earnings report. Hologic Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Hologic Inc. is Moderate Buy (2.25), with a target price of $79.6, which is +9.06% compared to the current price. The earnings rating for Hologic Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Hologic Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Hologic Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 13.58, ATR14 : 1.69, CCI20 : 127.85, Chaikin Money Flow : 0.26, MACD : 0.38, Money Flow Index : 52.56, ROC : 2.89, RSI : 45.94, STOCH (14,3) : 93.74, STOCH RSI : 1.00, UO : 51.95, Williams %R : -6.26), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Hologic Inc. in the last 12-months were: Benjamin J. Cohn (Option Excercise at a value of $434 798), Benjamin J. Cohn (Sold 15 644 shares of value $1 191 450 ), Jan Verstreken (Sold 6 500 shares of value $512 168 ), Sean S. Daugherty (Sold 2 179 shares of value $155 016 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (33.33 %)
5 (50.00 %)
5 (50.00 %)
Moderate Buy
1 (8.33 %)
1 (10.00 %)
1 (10.00 %)
Hold
7 (58.33 %)
4 (40.00 %)
4 (40.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
2.25
Moderate Buy
1.90
Moderate Buy
1.90

Hologic Inc.

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (64% of total sales, boosted by pandemic), breast health (21% of sales, suppressed by pandemic), surgical (12%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (75%), followed by Europe (16%), Asia (6%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

CEO: Stephen P. Macmillan

Telephone: +1 508 263-2900

Address: 250 Campus Drive, Marlborough 01752, MA, US

Number of employees: 5 814

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

52%48%

Bearish Bullish

57%43%

Bearish Bullish

61%39%

TipRanks News for HOLX


News

Stocktwits